Company: BIAF
Filing Date: 2025-06-02
Form Type: DEF 14A
Source: 0001641172-25-013280
Chunk: 13

Company: bioAffinity Technologies, Inc.
Filing Date: 2025-06-02
Form: DEF 14A
Chunk 13
---
 independent auditor during 2025, see “Report of the Audit Committee.”

Nominating and Corporate Governance Committee

The Nominating and Corporate Governance Committee
consists of Gary Rubin (Chairman), Peter Knight, and Robert Anderson, each of whom has been deemed independent by the Board in accordance
with the applicable Nasdaq Rules. The Nominating and Corporate Governance Committee is primarily responsible for identifying qualified
candidates for nomination to the Board and for developing and maintaining the Company’s corporate governance policies.

The responsibilities and duties of the Nominating
and Corporate Governance Committee are set forth in its charter and include the following:

| ● | identifying and screening individuals qualified to become members of the Board, consistent with Board-approved criteria;                                                                     |
| ● | making recommendations to the Board concerning the selection and approval of director-nominees to be submitted to a stockholder vote at the Annual Meeting, subject to the Board’s approval; |
| ● | developing and recommending for the Board’s approval standards for assessing whether a director has a relationship with the Company that would impair director independence; and             |
| ● | reporting regularly to the Board regarding the Nominating and Corporate Governance Committee’s actions and making recommendations to the Board as appropriate.                               |

| 7 |

For more information concerning the Nominating and
Corporate Governance Committee’s process of making director nominations and the current director nominees, see Proposal No. 1.

Compensation Committee

The Compensation Committee currently
consists of Peter Knight (Chairman), Stuart Diamond, and Jamie Platt, but upon conclusion of the Annual Meeting the Compensation Committee
will consist of Peter Knight (Chairman) and Jamie Platt. The Board has determined that each current and proposed Compensation
Committee member is independent according to the applicable Nasdaq Rules and the Company’s independence guidelines.

The responsibilities and duties of the Compensation
Committee are set forth in its charter and include the following:

| ● | reviewing and approving annually the corporate goals and objectives applicable to the CEO’s compensation, evaluating the CEO’s performance in light of those goals and objectives, and determining and approving the CEO’s compensation level based on the Compensation Committee’s evaluation; |
| ● | reviewing and approving the compensation of all of the Company’s other executive officers;                                                                                                                                                                                                      |
| ● | assessing, making recommendations to the Board regarding, and administering the Company’s incentive-compensation plans and equity-based plans, including designating the recipients, amounts, and terms and conditions applicable to the awards to be granted under each plan;                  |
| ● |